Full Text View
Tabular View
No Study Results Posted
Related Studies
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery
This study is currently recruiting participants.
Verified February 2013 by Roswell Park Cancer Institute
Study NCT01533948   Information provided by Roswell Park Cancer Institute

First Received on January 18, 2012.   Last Updated on February 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Melanoma
Stage IIIA Melanoma
Stage IIIB Melanoma
Stage IIIC Melanoma
Stage IV Melanoma
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
axitinib
laboratory biomarker analysis
pharmacogenomic studies
3'-deoxy-3'-[18F]fluorothymidine
positron emission tomography
Sponsors listed in this trial
Roswell Park Cancer Institute
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services